112 related articles for article (PubMed ID: 15448338)
1. Inhibition of infectious human herpesvirus 8 production by gamma interferon and alpha interferon in BCBL-1 cells.
Pozharskaya VP; Weakland LL; Offermann MK
J Gen Virol; 2004 Oct; 85(Pt 10):2779-2787. PubMed ID: 15448338
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of infection and replication of human herpesvirus 8 in microvascular endothelial cells by alpha interferon and phosphonoformic acid.
Krug LT; Pozharskaya VP; Yu Y; Inoue N; Offermann MK
J Virol; 2004 Aug; 78(15):8359-71. PubMed ID: 15254208
[TBL] [Abstract][Full Text] [Related]
3. Short duration of elevated vIRF-1 expression during lytic replication of human herpesvirus 8 limits its ability to block antiviral responses induced by alpha interferon in BCBL-1 cells.
Pozharskaya VP; Weakland LL; Zimring JC; Krug LT; Unger ER; Neisch A; Joshi H; Inoue N; Offermann MK
J Virol; 2004 Jun; 78(12):6621-35. PubMed ID: 15163753
[TBL] [Abstract][Full Text] [Related]
4. Alpha interferon inhibits human herpesvirus 8 (HHV-8) reactivation in primary effusion lymphoma cells and reduces HHV-8 load in cultured peripheral blood mononuclear cells.
Monini P; Carlini F; Stürzl M; Rimessi P; Superti F; Franco M; Melucci-Vigo G; Cafaro A; Goletti D; Sgadari C; Butto' S; Leone P; Chiozzini C; Barresi C; Tinari A; Bonaccorsi A; Capobianchi MR; Giuliani M; di Carlo A; Andreoni M; Rezza G; Ensoli B
J Virol; 1999 May; 73(5):4029-41. PubMed ID: 10196299
[TBL] [Abstract][Full Text] [Related]
5. Identification and rapid quantification of early- and late-lytic human herpesvirus 8 infection in single cells by flow cytometric analysis: characterization of antiherpesvirus agents.
Zoeteweij JP; Eyes ST; Orenstein JM; Kawamura T; Wu L; Chandran B; Forghani B; Blauvelt A
J Virol; 1999 Jul; 73(7):5894-902. PubMed ID: 10364341
[TBL] [Abstract][Full Text] [Related]
6. Type I consensus IFN (IFN-con1) gene transfer into KSHV/HHV-8-infected BCBL-1 cells causes inhibition of viral lytic cycle activation via induction of apoptosis and abrogates tumorigenicity in sCID mice.
D'Agostino G; Aricò E; Santodonato L; Venditti M; Sestili P; Masuelli L; Coletti A; Modesti A; Picchio G; Mosier DE; Ferrantini M; Belardelli F
J Interferon Cytokine Res; 1999 Nov; 19(11):1305-16. PubMed ID: 10574624
[TBL] [Abstract][Full Text] [Related]
7. A requirement for NF-kappaB induction in the production of replication-competent HHV-8 virions.
Sgarbanti M; Arguello M; tenOever BR; Battistini A; Lin R; Hiscott J
Oncogene; 2004 Jul; 23(34):5770-80. PubMed ID: 15235582
[TBL] [Abstract][Full Text] [Related]
8. Autocrine nerve growth factor is essential for cell survival and viral maturation in HHV-8-infected primary effusion lymphoma cells.
Pica F; Volpi A; Serafino A; Fraschetti M; Franzese O; Garaci E
Blood; 2000 May; 95(9):2905-12. PubMed ID: 10779438
[TBL] [Abstract][Full Text] [Related]
9. The targeting of primary effusion lymphoma cells for apoptosis by inducing lytic replication of human herpesvirus 8 while blocking virus production.
Klass CM; Krug LT; Pozharskaya VP; Offermann MK
Blood; 2005 May; 105(10):4028-34. PubMed ID: 15687238
[TBL] [Abstract][Full Text] [Related]
10. Glycolysis, Glutaminolysis, and Fatty Acid Synthesis Are Required for Distinct Stages of Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication.
Sanchez EL; Pulliam TH; Dimaio TA; Thalhofer AB; Delgado T; Lagunoff M
J Virol; 2017 May; 91(10):. PubMed ID: 28275189
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis delta virus replication in vitro is not affected by interferon-alpha or -gamma despite intact cellular responses to interferon and dsRNA.
McNair AN; Cheng D; Monjardino J; Thomas HC; Kerr IM
J Gen Virol; 1994 Jun; 75 ( Pt 6)():1371-8. PubMed ID: 7911507
[TBL] [Abstract][Full Text] [Related]
12. Optimization of chemical induction conditions for human herpesvirus 8 (HHV-8) reactivation with 12-O-tetradecanoyl-phorbol-13-acetate (TPA) from latently-infected BC-3 cells.
Ma W; Galvin TA; Ma H; Ma Y; Muller J; Khan AS
Biologicals; 2011 May; 39(3):158-66. PubMed ID: 21470875
[TBL] [Abstract][Full Text] [Related]
13. Lytic growth of human herpesvirus 8: morphological aspects.
Tinari A; Monini P; Marchetti M; Ammendolia MG; Leone P; Ensoli B; Superti F
Ultrastruct Pathol; 2000; 24(5):301-10. PubMed ID: 11071568
[TBL] [Abstract][Full Text] [Related]
14. Human interleukin-6 induces human herpesvirus-8 replication in a body cavity-based lymphoma cell line.
Song J; Ohkura T; Sugimoto M; Mori Y; Inagi R; Yamanishi K; Yoshizaki K; Nishimoto N
J Med Virol; 2002 Nov; 68(3):404-11. PubMed ID: 12226829
[TBL] [Abstract][Full Text] [Related]
15. Caspase-Dependent Suppression of Type I Interferon Signaling Promotes Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication.
Tabtieng T; Degterev A; Gaglia MM
J Virol; 2018 May; 92(10):. PubMed ID: 29514903
[TBL] [Abstract][Full Text] [Related]
16. Induction of HHV-8 lytic cycle replication by inflammatory cytokines produced by HIV-1-infected T cells.
Mercader M; Taddeo B; Panella JR; Chandran B; Nickoloff BJ; Foreman KE
Am J Pathol; 2000 Jun; 156(6):1961-71. PubMed ID: 10854219
[TBL] [Abstract][Full Text] [Related]
17. Suppression of Kaposi's Sarcoma-Associated Herpesvirus Infection and Replication by 5'-AMP-Activated Protein Kinase.
Cheng F; He M; Jung JU; Lu C; Gao SJ
J Virol; 2016 Jul; 90(14):6515-6525. PubMed ID: 27147746
[TBL] [Abstract][Full Text] [Related]
18. Chloroquine inhibits lytic replication of Kaposi's sarcoma-associated herpesvirus by disrupting mTOR and p38-MAPK activation.
Yang M; Huang L; Li X; Kuang E
Antiviral Res; 2016 Sep; 133():223-33. PubMed ID: 27521848
[TBL] [Abstract][Full Text] [Related]
19. Tumour necrosis factor-alpha, interferon-gamma and interferon-beta exert antiviral activity in nervous tissue cells.
Schijns VE; Van der Neut R; Haagmans BL; Bar DR; Schellekens H; Horzinek MC
J Gen Virol; 1991 Apr; 72 ( Pt 4)():809-15. PubMed ID: 1849968
[TBL] [Abstract][Full Text] [Related]
20. Induction of human herpesvirus-8 DNA replication and transcription by butyrate and TPA in BCBL-1 cells.
Yu Y; Black JB; Goldsmith CS; Browning PJ; Bhalla K; Offermann MK
J Gen Virol; 1999 Jan; 80 ( Pt 1)():83-90. PubMed ID: 9934688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
